Genetic and genomic testing can both play roles in diagnosing cardiovascular disease. Broadly speaking, genetics refers to the study of genes while genomics refers to the study of the entirety of a person’s genes, known as the genome. Genetic testing is the study of specific, individual genes and whether they are passed from one generation to the next. Genetic tests help determine if a patient has a specific altered gene that can lead to an inherited heart condition. Genomic testing looks broadly for gene alterations, or harmful changes, anywhere in the genetic code. Genomic testing looks at the make-up of genes a person is born with that can affect cardiovascular risk.
The CardioGenomic Testing Alliance is committed to raising awareness and utilization in both genetic and genomic testing in cardiology. CGTA is encouraged by the progress of genomic testing for inherited cardiovascular disease as actionable genes related to cardiovascular diseases continue to grow.
CGTA will consider genomic testing in cardiology to be an inclusive term that refers to both genetic testing and genomic testing in cardiology.